4.7 Article

High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland

Anthony O'Connor et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)

Review Pharmacology & Pharmacy

The sequential therapy regimen for Helicobacter pylori eradication

Javier P. Gisbert et al.

EXPERT OPINION ON PHARMACOTHERAPY (2010)

Article Medicine, General & Internal

Helicobacter pyloriInfection

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Pharmacology & Pharmacy

Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH

Julia Kirchheiner et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)

Article Pharmacology & Pharmacy

Effect of CYP2C19*2 and*17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians

Nicole G. Hunfeld et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)

Article Medicine, General & Internal

Meta-analysis:: duration of first-line proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication

Lorenzo Fuccio et al.

ANNALS OF INTERNAL MEDICINE (2007)

Review Gastroenterology & Hepatology

The effect of CYP2C19 polymorphisms on H-Pylori eradication rate in dual and triple first-line PPI therapies:: A meta-analysis

Sara Padol et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)

Article Medical Laboratory Technology

Helicobacter pylori: prevalence of antimicrobial resistance in clinical isolates

C. Hooton et al.

BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2006)

Article Gastroenterology & Hepatology

Meta-analysis:: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies

LA Fischbach et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)

Review Infectious Diseases

Patient compliance with antibiotic treatment for respiratory tract infections

P Kardas

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)

Review Infectious Diseases

Metronidazole resistance in Helicobacter pylori

PJ Jenks et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)

Article Gastroenterology & Hepatology

Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes

Y Horai et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)

Article Infectious Diseases

Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy

M Heep et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2000)